Dr Reddys Laboratories (RDY) Non-Current Receivables (2017 - 2025)
Historic Non-Current Receivables for Dr Reddys Laboratories (RDY) over the last 9 years, with Q3 2025 value amounting to $42.6 million.
- Dr Reddys Laboratories' Non-Current Receivables rose 5647.57% to $42.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.6 million, marking a year-over-year increase of 5647.57%. This contributed to the annual value of $21.0 million for FY2025, which is 5333.33% down from last year.
- According to the latest figures from Q3 2025, Dr Reddys Laboratories' Non-Current Receivables is $42.6 million, which was up 5647.57% from $21.0 million recorded in Q1 2025.
- In the past 5 years, Dr Reddys Laboratories' Non-Current Receivables registered a high of $44.8 million during Q1 2024, and its lowest value of $718150.0 during Q1 2022.
- Moreover, its 5-year median value for Non-Current Receivables was $29.9 million (2023), whereas its average is $25.5 million.
- As far as peak fluctuations go, Dr Reddys Laboratories' Non-Current Receivables crashed by 9325.04% in 2021, and later skyrocketed by 445155.0% in 2023.
- Over the past 5 years, Dr Reddys Laboratories' Non-Current Receivables (Quarter) stood at $42.8 million in 2021, then decreased by 10.26% to $38.4 million in 2022, then tumbled by 90.62% to $3.6 million in 2023, then soared by 654.47% to $27.2 million in 2024, then skyrocketed by 56.48% to $42.6 million in 2025.
- Its last three reported values are $42.6 million in Q3 2025, $21.0 million for Q1 2025, and $27.2 million during Q3 2024.